Dry Eye Disease Market, By Disease Type (Aqueous Deficient Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By Product (Topical Corticosteroids, Cyclosporine, Oral Omega Supplements, Punctual Plugs, and Artificial Tears), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Dry Eye Disease Market was valued at US$ 7 Billion in 2024 and is projected to grow at a CAGR of 7.20% to reach US$ 14.1 Billion by 2034.

Dry Eye Disease (DED) is a multifactorial illness that affects the ocular surface and is distinguished by a disruption in tear film homeostasis. It is also known as dry eye syndrome (DES), keratoconjunctivitis sicca (KCS), or ocular surface disease (OSD). Symptoms of the illness include dryness, irritation, burning, redness, and blurred vision, which can be caused by a variety of underlying reasons.

According to the Tear Film and Ocular Surface Society (TFOS), dry eye is a multifactorial illness of the ocular surface characterized by a loss of tear film homeostasis and ocular symptoms. The condition is divided into two categories: aqueous-deficient dry eye and evaporative dry eye. Aqueous-deficient dry eye is characterized by insufficient tear production, which is commonly caused by systemic diseases or drugs. Evaporative dry eye, on the other hand, is defined by excessive tear film evaporation, which is usually caused by meibomian gland dysfunction.

Dry eye disease can be caused by various factors, including local ocular issues, systemic diseases, sociodemographic characteristics, environmental conditions, and iatrogenic causes. These include systemic medications, skin diseases, meibomian gland dysfunction, ophthalmic surgery, chemical burns, ocular allergies, decreased androgen levels, computer usage, vitamin deficiency, and corneal sensation.The tear film consists of three layers: lipid, aqueous, and mucin. The lipid layer, produced by meibomian glands, reduces tear evaporation. The aqueous layer, produced by lacrimal glands, contains water, metabolites, electrolytes, peptides, and proteins. The mucin layer stabilizes the tear film. Dry eye disease causes the tear film to become unstable, leading to hyperosmolarity and inflammation, potentially damaging the ocular surface.

Dry eye disease is diagnosed through an eye exam, which includes tear film tests, ocular surface review, and symptom evaluation. Treatment options include artificial tears, lubricating eye drops, dietary changes, anti-inflammatory drugs, and surgical interventions. The choice depends on the underlying cause and severity of the condition. Research on DED has advanced significantly, with recent studies focusing on inflammation, meibomian gland dysfunction, and environmental influences to refine patient care strategies and improve outcomes.

Drivers of the Dry Eye Disease Market:  

Emerging Markets:

• Growing economies, vast healthcare infrastructure, and professionals bring new opportunities to the global market. The dry eye disease market is expanding in emerging markets like India, China, Brazil, Southeast Asia, Latin America, and the Middle East & Africa.
• India's growing population, improved healthcare infrastructure, and high prevalence of the disease make it a significant market for treatment. China's 20% prevalence of dry eye disorder in 2022 also makes it a significant market. Pharmaceutical companies are expanding their businesses in these regions to meet the global demand.

Telehealth and Telemedicine:

• The rapidly popularizing telehealth and telemedicine services improve patient outcomes and enhance treatment with consultations. Telehealth and telemedicine have significantly improved the management and treatment of dry eye disease.
• Teleconsultation platforms allow patients to initiate consultations with eye care professionals remotely, while telemonitoring reduces the need for in-person visits. Telecollaboration enhances collaboration and patient outcomes.
• Telemedicine also enables remote testing, increasing patient access for rural and underserved populations. It addresses medical staff shortages in ophthalmology by reducing in-person consultations.
• Telehealth offers convenience, streamlined care, and improved patient outcomes. Best practices include designating telehealth-only clinics and using HIPAA-compliant software.

Restrains in the Dry Eye Disease Market:

Competition from Generic items:

• The availability of generic items can raise competition and diminish market share for branded products, hence reducing market growth.

Lack of Awareness:

• Limited awareness of dry eye illness and its symptoms might lead to delayed diagnosis and treatment, resulting in lower market growth.

Lack of defined Diagnostic Criteria:

• The absence of defined diagnostic criteria might result in inconsistent diagnosis and treatment, reducing market growth.

Dry Eye Disease Market Segmentation:

Dry Eye Disease Market is segmented based on Disease Type, Product, Distribution Channel, and Region.

Disease Type Insight

On the basis of Disease Type, Dry Eye Disease Market is segmented into Aqueous Deficient Dry Eye Syndrome, Evaporative Dry Eye Syndrome.

Product Insights

On the basis of Product, Dry Eye Disease Market is segmented into Topical Corticosteroids, Cyclosporine, Oral Omega Supplements, Punctual Plugs, and Artificial Tears.

Distribution Channel Insights

On the basis of Distribution Channel, Dry Eye Disease Market is segmented into Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.

Dry Eye Disease Market Regional Insights:

On region the Dry Eye Disease Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market is estimated to witness a significantly high revenue share over the forecast period due to rising prevalence of dry eyes disorder, growing geriatric population, continuous technological development, and increased demand for anti-inflammatory drugs.

Asia Pacific market is estimated to witness a fastest revenue share over the forecast period due to growing population, increased prevalence of dry eye disease, improved healthcare infrastructure and presence of major players such as Santen Pharmaceuticals and Otsuka Pharmaceuticals Co. Ltd., expected to drive market.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034

Dry Eye Disease Market Key Players:

The key players operating the Dry Eye Disease Market includes, AbbVie Inc., Johnson & Johnson Services Inc., Otsuka Pharmaceuticals Co. Ltd., Novartis AG, AFT Pharmaceuticals, OASIS Medical, Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Ltd., Bausch & Lomb, and Others.

Recent Development:

  The New Launched Product News,

·In April 2023, Sun Pharmaceutical Industries Ltd., (India) launched new medication for treating dry eye disease. The new launched ‘Cequa’ has become the first dry eye treatment available in India which is delivered with latest nanomicellar technology.

·In June 2023, the U.S. FDA (Food and Drug Administration) has approved two novel therapies for patients with dry eye disorder. The new approved therapies are ‘Miebo’, that address the excessive tear evaporation in dry eye and ‘Veyve’ a preservative-free and water-free solution based on EyeSol technology.

Key Issues Addressed

1. Company Profiles

• AbbVie Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Johnson & Johnson Services Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Otsuka Pharmaceuticals Co. Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Novartis AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• AFT Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• OASIS Medical
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Santen Pharmaceutical Co. Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Takeda Pharmaceutical Company Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Bausch & Lomb
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

1. The Last Word
   • Future Impact
   • About Us
   • Contact

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for medical carts Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Disease Type
     • Market Snippet, By Product
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restrains
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Dry Eye Disease Market, By Disease Type, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Aqueous Deficient Dry Eye Syndrome
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Evaporative Dry Eye Syndrome
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

1. Dry Eye Disease Market, By Product, Forecast Period up to 10 Years, (US$ Bn)
   • Overview                                      
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
     • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
     • Segment Trends
   • Topical Corticosteroids
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
   • Cyclosporine
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
   • Oral Omega Supplements
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
   • Punctual Plugs
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
   • Artificial Tears
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
2. Dry Eye Disease Market, By Distribution Channel, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Hospital Pharmacy
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Online Pharmacy
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Retail Pharmacy
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

1. Dry Eye Disease Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
     • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
       • UK
       • France
       • Germany
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
       • India
       • Japan
       • South Korea
       • China
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years

• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• GCC
• Israel
• South Africa
• Rest of Middle East

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis